The Biden administration on Wednesday proposed new privacy protections to prevent women's health information from being used to investigate or sue people who obtain or facilitate abortions.
A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.
The U.S. government on Monday appealed a Texas judge's decision to suspend the Food and Drug Administration's 23-year-old approval of a key abortion drug, saying the ruling endangered women's health by blocking access to a pill long deemed safe.
Options include Justice Dept. backing for legal challenges brought against manufacturers and pharmacies, and providing legal advice on how to continue dispensing the pills, sources said.
U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas on Friday suspended approval of the abortion pill mifepristone, which will essentially make sales of the pill illegal in the U.S., while a legal challenge proceeds.